Needle-free influenza vaccination

被引:100
作者
Amorij, Jean-Pierre [2 ,3 ,4 ]
Hinrichs, Wouter L. J. [2 ]
Frijlink, Henderik W. [2 ]
Wilschut, Jan C. [1 ]
Huckriede, Anke [1 ]
机构
[1] Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, NL-9700 RB Groningen, Netherlands
[2] Univ Med Ctr Groningen, Dept Pharmaceut Technol & Biopharm, NL-9700 RB Groningen, Netherlands
[3] Univ Groningen, Groningen, Netherlands
[4] Netherlands Vaccine Inst, Res & Dev Unit, Bilthoven, Netherlands
关键词
HEAT-LABILE ENTEROTOXIN; EPIDERMAL POWDER IMMUNIZATION; MUCOSAL IMMUNE-RESPONSES; SINGLE INTRANASAL IMMUNIZATION; MODIFIED PULMONARY SURFACTANT; HUMAN RESPIRATORY SECRETIONS; IGG IMMUNOLOGICAL RESPONSES; TRANSDERMAL DRUG-DELIVERY; CYTOTOXIC T-LYMPHOCYTE; ESCHERICHIA-COLI;
D O I
10.1016/S1473-3099(10)70157-2
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
Vaccination is the cornerstone of influenza control in epidemic and pandemic situations. Influenza vaccines are typically given by intramuscular injection. However, needle-free vaccinations could offer several distinct advantages over intramuscular injections: they are pain-free, easier to distribute, and easier to give to patients, and their use could reduce vaccination costs. Moreover, vaccine delivery via the respiratory tract, alimentary tract, or skin might elicit mucosal immune responses at the site of virus entry and better cellular immunity, thus improving effectiveness. Although various needle-free vaccination methods for influenza have shown preclinical promise, few have progressed to clinical trials-only live attenuated intranasal vaccines have received approval, and only in some countries. Further clinical investigation is needed to help realise the potential of needle-free vaccination for influenza.
引用
收藏
页码:699 / 711
页数:13
相关论文
共 195 条
[1]
Intranasal, cold-adapted, live, attenuated influenza vaccine [J].
Abramson, JS .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (12) :1103-1104
[2]
Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines [J].
Alarcon, Jason B. ;
Hartley, Andrea Waterston ;
Harvey, Noel G. ;
Mikszta, John A. .
CLINICAL AND VACCINE IMMUNOLOGY, 2007, 14 (04) :375-381
[3]
N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination:: Biological properties and immunogenicity in a mouse model [J].
Amidi, Maryam ;
Romeijn, Stefan G. ;
Verhoef, J. Coos ;
Junginger, Hans E. ;
Bungener, Laura ;
Huckriede, Anke ;
Crommelin, Daan J. A. ;
Jiskoot, Wim .
VACCINE, 2007, 25 (01) :144-153
[4]
Development of stable influenza vaccine powder formulations: Challenges and possibilities [J].
Amorij, J-P. ;
Huckriede, A. ;
Wischut, J. ;
Frijlink, H. W. ;
Hinrichs, W. L. J. .
PHARMACEUTICAL RESEARCH, 2008, 25 (06) :1256-1273
[5]
Towards an oral influenza vaccine: Comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model [J].
Amorij, J-P. ;
Westra, T. A. ;
Hinrichs, W. L. J. ;
Huckriede, A. ;
Frijlink, H. W. .
VACCINE, 2007, 26 (01) :67-76
[6]
Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice [J].
Amorij, J-P. ;
Saluja, V. ;
Petersen, A. H. ;
Hinrichs, W. L. J. ;
Huckriede, A. ;
Frijlink, H. W. .
VACCINE, 2007, 25 (52) :8707-8717
[7]
[Anonymous], 2005, Wkly Epidemiol Rec, V80, P279
[8]
Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years Randomized, controlled, phase III trial [J].
Arnou, Robert ;
Eavis, Patrick ;
De Juanes Pardo, Jose-Ramon ;
Ambrozaitis, Arvydas ;
Kazek, Marie-Pierre ;
Weber, Francoise .
HUMAN VACCINES, 2010, 6 (04) :346-354
[9]
Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study [J].
Arnou, Robert ;
Icardi, Giancarlo ;
De Decker, Marijke ;
Ambrozaitis, Arvydas ;
Kazek, Marie-Pierre ;
Weber, Francoise ;
Van Damme, Pierre .
VACCINE, 2009, 27 (52) :7304-7312
[10]
Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity [J].
Arulanandam, BP ;
O'Toole, M ;
Metzger, DW .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) :940-949